Tele2 AB (publ)
Tele2 AB (publ) (TLTZF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Tele2 AB (publ) (TLTZF), covering cash flow, earnings, and balance sheets.
Tele2 AB (publ) (TLTZF) Income Statement & Financial Overview
Explore comprehensive income reports for Tele2 AB (publ) TLTZF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7.15B | $7.78B | $7.39B | $7.26B |
| Cost of Revenue | $4.02B | $4.50B | $4.11B | $4.09B |
| Gross Profit | $3.13B | $3.28B | $3.28B | $3.16B |
| Gross Profit Ratio | $0.44 | $0.42 | $0.44 | $0.44 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.59B | $1.85B | $1.67B | $1.81B |
| Operating Expenses | $1.82B | $1.80B | $1.62B | $1.76B |
| Total Costs & Expenses | $5.84B | $6.30B | $5.73B | $5.86B |
| Interest Income | $15.00M | $16.00M | $27.00M | $36.00M |
| Interest Expense | $236.00M | $294.00M | $296.00M | $308.00M |
| Depreciation & Amortization | $1.52B | $0.00 | $1.47B | $1.48B |
| EBITDA | $2.84B | $1.50B | $3.16B | $2.93B |
| EBITDA Ratio | $0.40 | $0.19 | $0.43 | $0.40 |
| Operating Income | $1.31B | $1.48B | $1.66B | $1.40B |
| Operating Income Ratio | $0.18 | $0.19 | $0.23 | $0.19 |
| Other Income/Expenses (Net) | -$231.00M | -$271.00M | -$272.00M | -$253.00M |
| Income Before Tax | $1.08B | $1.21B | $1.39B | $1.15B |
| Income Before Tax Ratio | $0.15 | $0.16 | $0.19 | $0.16 |
| Income Tax Expense | $209.00M | $238.00M | $283.00M | $206.00M |
| Net Income | $875.00M | $971.00M | $1.11B | $958.00M |
| Net Income Ratio | $0.12 | $0.12 | $0.15 | $0.13 |
| EPS | $1.26 | $1.40 | $1.60 | $1.36 |
| Diluted EPS | $1.26 | $1.39 | $1.59 | $1.36 |
| Weighted Avg Shares Outstanding | $692.39M | $692.17M | $692.39M | $692.39M |
| Weighted Avg Shares Outstanding (Diluted) | $696.58M | $696.55M | $696.86M | $692.39M |
Over the past four quarters, Tele2 AB (publ) demonstrated steady revenue growth, increasing from $7.26B in Q2 2024 to $7.15B in Q1 2025. Operating income reached $1.31B in Q1 2025, maintaining a consistent 18% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $2.84B, reflecting operational efficiency. Net income dropped to $875.00M, with EPS at $1.26. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan